Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

about

Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).

P2860

Q50932712-5DCD9CE9-B2B8-4182-A44E-128E1A8A46B2

P2860

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

Item

http://www.wikidata.org/entity/Q39213501

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Conversion surgery after combi ...... r far-advanced gastric cancer.

@en

Conversion surgery after combi ...... r far-advanced gastric cancer.

@nl

type

Item

label

Conversion surgery after combi ...... r far-advanced gastric cancer.

@en

Conversion surgery after combi ...... r far-advanced gastric cancer.

@nl

prefLabel

Conversion surgery after combi ...... r far-advanced gastric cancer.

@en

Conversion surgery after combi ...... r far-advanced gastric cancer.

@nl

P1476

Conversion surgery after combi ...... r far-advanced gastric cancer.

@en

P2093

Hiroaki Mieno

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Moriya

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Higuchi

http://www.w3.org/2001/XMLSchema#string

Kei Hosoda

http://www.w3.org/2001/XMLSchema#string

Keishi Yamashita

http://www.w3.org/2001/XMLSchema#string

Masahiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Mizutomo Azuma

http://www.w3.org/2001/XMLSchema#string

Natsuya Katada

http://www.w3.org/2001/XMLSchema#string

Satoshi Tanabe

http://www.w3.org/2001/XMLSchema#string

Shouko Komori

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

P31

scholarly article

P356

10.1007/S00595-017-1512-Z

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28365892

http://www.w3.org/2001/XMLSchema#string

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

about

P2860

P2860

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698